Electrocardiographic and Biochemical Adverse Effects of Meglumine Antimoniate (MA) During Treatment of Syrian Cutaneous Leishmaniasis Patients. J Pak Assoc Dermatol 2016, 23 (4), 412-417. https://doi.org/10.66344/jpad.v23i4.289.